Rallybio Corp. (RLYB)
16.64
+0.24
(+1.46%)
USD |
NASDAQ |
Oct 23, 16:00
16.48
-0.16
(-0.96%)
After-Hours: 20:00
Rallybio Total Assets (Quarterly) : 98.06M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.06M |
| March 31, 2026 | 54.47M |
| December 31, 2025 | 62.26M |
| September 30, 2025 | 67.66M |
| June 30, 2025 | 51.00M |
| March 31, 2025 | 57.98M |
| December 31, 2024 | 68.11M |
| September 30, 2024 | 79.01M |
| June 30, 2024 | 92.43M |
| March 31, 2024 | 99.36M |
| December 31, 2023 | 115.62M |
| September 30, 2023 | 133.19M |
| Date | Value |
|---|---|
| June 30, 2023 | 147.58M |
| March 31, 2023 | 162.32M |
| December 31, 2022 | 180.44M |
| September 30, 2022 | 143.67M |
| June 30, 2022 | 155.61M |
| March 31, 2022 | 169.35M |
| December 31, 2021 | 182.18M |
| September 30, 2021 | 193.86M |
| June 30, 2021 | 120.10M |
| March 31, 2021 | 129.35M |
| December 31, 2020 | 141.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.567M |
| Shareholders Equity (Quarterly) | 94.50M |
| Current Ratio | 27.26 |
| Net Debt Paydown Yield | 0.03% |